Cosmetic Services
Our aesthetic services, including Botox and Daxxify, offer safe, effective ways to smooth fine lines and restore a refreshed, youthful appearance—without changing who you are. Whether you're new to injectables or looking for longer-lasting results, we're here to help you feel confident in your own skin.
BOTOX Cosmetic
BOTOX Cosmetic is a FDA-approved product used to temporarily improve the appearance of moderate to severe frown lines, crow’s feet lines, and forehead lines in adults. It works by reducing muscle activity beneath the skin’s surface, resulting in a smoother appearance. Some key points about BOTOX® Cosmetic include: - It’s the only product of its kind approved for treating these three areas. - 92% of people prefer BOTOX® Cosmetic over other brands. - 8 out of 10 physicians use BOTOX® Cosmetic for themselves or their family members. - Potential side effects include muscle weakness, vision problems, and allergic reactions. - The effect is temporary and may last up to 4 months for frown lines. - It’s essential to inform your doctor about medical conditions and medications. - There have been no confirmed cases of the spread of toxin effects when used at recommended doses.
BOTOX Cosmetic Data
*Based on a 2020 survey of 142 respondents who were asked to select which brand(s) of neurotoxin they had ever requested to receive from their doctor.
†Based on a 2018 survey of 484 healthcare providers
DAXXIFY:
DAXXIFY is a neuromodulator used to treat glabellar lines and has undergone a significant Phase 3 clinical trial program. Key information about DAXXIFY includes: It’s been tested for both aesthetic and therapeutic purposes. - In clinical trials, it showed a high rate of wrinkle severity reduction. - Side effects may include injection site reactions and headache. - DAXXIFY® is not approved for the treatment of conditions other than glabellar lines. - It’s essential not to exceed the recommended dose and frequency of administration. - In case of respiratory, speech, or swallowing difficulties, patients should seek immediate medical attention.
DAXXIFY Phase 3 Clinical Trial Results
DAXXIFY's largest Phase 3 clinical trial program was the SAKURA program, which evaluated its efficacy and safety for treating moderate to severe glabellar lines. This program encompassed over 2,700 patients and approximately 4,200 treatments, making it the most extensive Phase 3 clinical trial for glabellar lines to date.
Book your appointment today!
Call us at 907-929-2222
Text us at 1-866-841-1865